Financial Architects (New Jersey)’s Achillion Pharmaceuticals ACHN Stock Holding History

Financial Architects (New Jersey)’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,200	Closed	-$4K	–	1572
2019 Q1	$4K	Hold	1,200	–	–	﹤0.01%	1276
2018 Q4	$2K	Hold	1,200	–	–	﹤0.01%	1244
2018 Q3	$4K	Hold	1,200	–	–	﹤0.01%	1279
2018 Q2	$3K	Hold	1,200	–	–	﹤0.01%	1191
2018 Q1	$4K	Hold	1,200	–	–	﹤0.01%	1280
2017 Q4	$3K	Buy	1,200 +200	+20%	+$727	﹤0.01%	1393
2017 Q3	$4K	Hold	1,000	–	–	﹤0.01%	1342
2017 Q2	$5K	Hold	1,000	–	–	﹤0.01%	1306
2017 Q1	$4K	Hold	1,000	–	–	﹤0.01%	1358
2016 Q4	$4K	Hold	1,000	–	–	﹤0.01%	1214
2016 Q3	$8K	Sell	1,000 -1,300	-57%	-$11.1K	﹤0.01%	1060
2016 Q2	$18K	Buy	+2,300	New	+$19.7K	0.01%	829

Other funds holding ACHN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Financial Architects (New Jersey)'s ACHN Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Achillion Pharmaceuticals (ACHN) in Q2 2019, closing a stake of 1,200 shares — an estimated $4K sold.

Financial Architects (New Jersey) first reported a position in ACHN in Q2 2016 and held it in 12 quarters. The position peaked at $18K in Q2 2016. 114 funds tracked by Wall St. Rank hold ACHN as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Achillion Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 1,200 Achillion Pharmaceuticals shares in Q2 2019, an estimated $4K.
Financial Architects (New Jersey) first reported a position in Achillion Pharmaceuticals in Q2 2016 and held it in 12 quarters.
Financial Architects (New Jersey)'s Achillion Pharmaceuticals position peaked at $18K in Q2 2016.
114 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.